<?xml version="1.0" encoding="UTF-8"?>
<ref id="B21">
 <label>21.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>van Dissel</surname>
    <given-names>JT</given-names>
   </name>
   <name>
    <surname>Joosten</surname>
    <given-names>SA</given-names>
   </name>
   <name>
    <surname>Hoff</surname>
    <given-names>ST</given-names>
   </name>
   <name>
    <surname>Soonawala</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Prins</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Hokey</surname>
    <given-names>DA</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>A novel liposomal adjuvant system, CAF01, promotes long-lived 
   <italic>Mycobacterium tuberculosis</italic>-specific T-cell responses in human
  </article-title>. 
  <source>Vaccine.</source> (
  <year>2014</year>) 
  <volume>32</volume>:
  <fpage>7098</fpage>â€“
  <lpage>107</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2014.10.036</pub-id>
  <?supplied-pmid 25454872?>
  <pub-id pub-id-type="pmid">25454872</pub-id>
 </mixed-citation>
</ref>
